Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Shanghai Licheng Biotechnology divulges CLRN3-targeting nucleic acids

Nov. 18, 2021

Betta Pharmaceuticals identifies PTPN11 inhibitors

Nov. 18, 2021

GNT Biotech & Medicals presents new HDAC inhibitors

Nov. 18, 2021

Medshine Discovery discloses new MAPK inhibitors

Nov. 18, 2021

Novel STING agonist RVU-27065 shows potency in EMT6 breast cancer model

Nov. 18, 2021

PCC-1, an orally active HPK1 inhibitor with strong antitumor activity

Nov. 18, 2021

CRV-431 significantly decreases growth of liver tumors in mouse model of liver cancer

Nov. 17, 2021

Pyramid licenses rights to MPS1 inhibitor VRN-08 from Voronoi

Nov. 17, 2021

Accutar Biotechnology describes new compounds for cancer

Nov. 17, 2021

Shenzhen Jingtai Technology discloses new Ret inhibitors

Nov. 17, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...